Vanacore N - Search Results

1

Cholinesterase inhibitors: drugs looking for a disease?

Maggini M, Vanacore N, Raschetti R. Maggini M, et al. Among authors: vanacore n. PLoS Med. 2006 Apr;3(4):e140. doi: 10.1371/journal.pmed.0030140. Epub 2006 Apr 11. PLoS Med. 2006. PMID: 16597173 Free PMC article. Review.

2

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease.

Raschetti R, Maggini M, Sorrentino GC, Martini N, Caffari B, Vanacore N. Raschetti R, et al. Among authors: vanacore n. Eur J Clin Pharmacol. 2005 Jul;61(5-6):361-8. doi: 10.1007/s00228-005-0946-1. Epub 2005 May 24. Eur J Clin Pharmacol. 2005. PMID: 15912389 Clinical Trial.

3

[The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests].

Sorrentino GC, Caffari B, Vanacore N, Maggini M, Raschetti R. Sorrentino GC, et al. Among authors: vanacore n. Ann Ist Super Sanita. 2005;41(1):63-8. Ann Ist Super Sanita. 2005. PMID: 16037652 Review. Italian.

4

[Use of neuropsychological tests in the Cronos Project].

Bianchi G, Gasparini M, Caffari B, Sorrentino GC, Bianchi C, Bruno G, Maggini M, Raschetti R, Vanacore N. Bianchi G, et al. Among authors: vanacore n. Ann Ist Super Sanita. 2005;41(1):69-74. Ann Ist Super Sanita. 2005. PMID: 16037653 Italian.

5

Biomarkers in dementia.

Vanacore N, Galeotti F, Maggini M, Raschetti R. Vanacore N, et al. Arch Neurol. 2007 Sep;64(9):1356; author reply 1357-9. doi: 10.1001/archneur.64.9.1356. Arch Neurol. 2007. PMID: 17846281 No abstract available.

6

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.

Raschetti R, Albanese E, Vanacore N, Maggini M. Raschetti R, et al. Among authors: vanacore n. PLoS Med. 2007 Nov 27;4(11):e338. doi: 10.1371/journal.pmed.0040338. PLoS Med. 2007. PMID: 18044984 Free PMC article. Review.

7

Memantine in moderately-severe-to-severe Alzheimer's disease: a postmarketing surveillance study.

Clerici F, Vanacore N, Elia A, Spila-Alegiani S, Pomati S, Da Cas R, Raschetti R, Mariani C; Memantine Lombardy Study Group. Clerici F, et al. Among authors: vanacore n. Drugs Aging. 2009;26(4):321-32. doi: 10.2165/00002512-200926040-00003. Drugs Aging. 2009. PMID: 19476399

8

How are the interests of incapacitated research participants protected through legislation? An Italian study on legal agency for dementia patients.

Gainotti S, Fusari Imperatori S, Spila-Alegiani S, Maggiore L, Galeotti F, Vanacore N, Petrini C, Raschetti R, Mariani C, Clerici F. Gainotti S, et al. Among authors: vanacore n. PLoS One. 2010 Jun 16;5(6):e11150. doi: 10.1371/journal.pone.0011150. PLoS One. 2010. PMID: 20585400 Free PMC article.

9

Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study.

Clerici F, Vanacore N, Elia A, Spila-Alegiani S, Pomati S, Da Cas R, Raschetti R, Mariani C; Memantine Lombardy Study Group. Clerici F, et al. Among authors: vanacore n. Neurol Sci. 2012 Feb;33(1):23-31. doi: 10.1007/s10072-011-0618-0. Epub 2011 May 17. Neurol Sci. 2012. PMID: 21584738

10

Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.

Rafaniello C, Lombardo F, Ferrajolo C, Sportiello L, Parretta E, Formica R, Potenza S, Rinaldi B, Irpino A, Raschetti R, Vanacore N, Rossi F, Capuano A. Rafaniello C, et al. Among authors: vanacore n. Eur J Clin Pharmacol. 2014 Feb;70(2):187-95. doi: 10.1007/s00228-013-1588-3. Epub 2013 Oct 22. Eur J Clin Pharmacol. 2014. PMID: 24145814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page